Gilead Sciences Inc
MIL:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
MIL:GILD
Watchlist
Price: 68.88 EUR 1.09% Market Closed
Market Cap: 85.9B EUR

Wall Street
Price Targets

GILD Price Targets Summary
Gilead Sciences Inc

Wall Street analysts forecast GILD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GILD is 75.69 EUR with a low forecast of 59.3 EUR and a high forecast of 89.83 EUR.

Lowest
Price Target
59.3 EUR
14% Downside
Average
Price Target
75.69 EUR
10% Upside
Highest
Price Target
89.83 EUR
30% Upside
Gilead Sciences Inc Competitors:
Price Targets
ADAG
Adagene Inc
418% Upside
TECX
AVROBIO Inc
288% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
59% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
70% Upside
EXEL
Exelixis Inc
5% Upside
214450
PharmaResearch Co Ltd
94% Upside
MDXG
MiMedx Group Inc
81% Upside

Revenue
Forecast

Revenue Estimate
Gilead Sciences Inc

For the last 13 years the compound annual growth rate for Gilead Sciences Inc's revenue is 10%. The projected CAGR for the next 4 years is 4%.

10%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Gilead Sciences Inc

For the last 13 years the compound annual growth rate for Gilead Sciences Inc's operating income is 8%. The projected CAGR for the next 4 years is 11%.

8%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Gilead Sciences Inc

For the last 13 years the compound annual growth rate for Gilead Sciences Inc's net income is -13%. The projected CAGR for the next 4 years is 127%.

-13%
Past Growth
127%
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GILD's stock price target?
Price Target
75.69 EUR

According to Wall Street analysts, the average 1-year price target for GILD is 75.69 EUR with a low forecast of 59.3 EUR and a high forecast of 89.83 EUR.

What is Gilead Sciences Inc's Revenue forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Gilead Sciences Inc's revenue is 10%. The projected CAGR for the next 4 years is 4%.

What is Gilead Sciences Inc's Operating Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Gilead Sciences Inc's operating income is 8%. The projected CAGR for the next 4 years is 11%.

What is Gilead Sciences Inc's Net Income forecast?
Projected CAGR
127%

For the last 13 years the compound annual growth rate for Gilead Sciences Inc's net income is -13%. The projected CAGR for the next 4 years is 127%.

Back to Top